PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference

BOSTON, Sept. 2 /PRNewswire-FirstCall/ -- PAREXEL International
Corporation (Nasdaq: PRXL) announced today it will be presenting at the Thomas
Weisel Partners Healthcare Conference in Boston, MA.Josef von Rickenbach,
Chairman and Chief Executive Officer will be making a formal presentation on
PAREXEL at 3:50 p.m. EDT on Thursday, September 4, 2008.
A live webcast of this presentation will be available under the "Upcoming
Events" section on PAREXEL's "Investors" homepage at www.PAREXEL.com. A replay
of the presentation will be available until October 4, 2008.
About the Company
PAREXEL International Corporation is a leading global biopharmaceutical
services organization, providing a broad range of knowledge-based contract
research, medical communications and consulting services to the worldwide
pharmaceutical, biotechnology and medical device industries. Committed to
providing solutions that expedite time-to-market and peak-market penetration,
PAREXEL has developed significant expertise across the development and
commercialization continuum, from drug development and regulatory consulting
to clinical pharmacology, clinical trials management, medical education and
reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides
advanced technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston, Massachusetts,
PAREXEL operates in 69 locations throughout 52 countries around the world, and
has over 8,800 employees. For more information about PAREXEL International
visit www.PAREXEL.com.
PAREXEL is a registered trademark of PAREXEL International Corporation,
and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All
other names or marks may be registered trademarks or trademarks of their
respective business and are hereby acknowledged.
CONTACT: Jill Baker, Vice President of Investor Relations
+1-781-434-4118

SOURCE PAREXEL International Corporation

Jill Baker, Vice President of Investor Relations, +1-781-434-4118